17 reports

THESE DELIVERY DEVICES AND ACTIVATING AGENTS ARE NOT TRACKED UNDER THIS SEGMENT.

  • Therapy
  • Australasia
  • Forecast
  • Market Size
  • PolyNovo

HE ALSO HOLDS AN MCHEM IN CHEMISTRY WITH MEDICINAL CHEMISTRY FROM THE UNIVERSITY OF NEWCASTLE UPON TYNE WHERE HE STUDIED CELLULAR DRUG DELIVERY SYSTEMS AND THE EFFECT OF THE ANTITUMOR AGENT APOPTIN.

  • Therapy
  • Australasia
  • Oceania
  • Merck & Co., Inc.
  • Novartis AG
  • STARPHARMA RAISES USD23 MILLION IN PRIVATE PLACEMENT OF SHARES
  • EQUITY OFFERING

Commenting on the DEP drug delivery portfolio, Dr Fairley said: " It' s been particularly gratifying to have a set of clinical results validate the benefits of our DEP drug delivery platform, which we' d consistently seen across multiple preclinical st

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Australasia
  • Starpharma Holdings Limited

The company focuses on developing pharmaceutical products based on its transdermal drug delivery system, DermaSys.

  • Pharmaceutical
  • Therapy
  • Australasia
  • Supply
  • Clinigen Group plc
  • POLYACTIVA RAISES USD11.7 MILLION IN VENTURE FINANCING

THESE DELIVERY DEVICES AND ACTIVATING AGENTS ARE NOT TRACKED UNDER THIS SEGMENT.

  • Therapy
  • Australasia
  • Australia
  • Market Size
  • AirXpanders, Inc.

drug delivery devices and specialized sectors with two deals each during the period 2012 to YTD 2018.

  • Pharmaceutical
  • Therapy
  • Australasia
  • Australia
  • Sirtex Medical Limited
  • CSL Ltd, Medical Devices Deals, 2012 to YTD 2018

The drug candidate is a monoclonal antibody act against interleukin-## receptor alpha ## and IL-##.

  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • Australasia
  • CSL Limited
  • Deal status
  • PARTNERSHIP - DEAL REPORTS

Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement ##M Drug Delivery Systems Phosphagenics Ltd Announced Partnership Co-development Nov ##, 2010 Company information: Partners Partner ##: ##M Drug Delivery Systems Co

  • Immunology
  • Therapy
  • Australasia
  • Corporate Finance
  • Phosphagenics Limited
  • Introduction

It established SALVAT Biotech to pursue advancements in molecular diagnosis, regenerative medicine and new forms of drug delivery.

  • Therapy
  • Australasia
  • World
  • Product Initiative
  • Actinogen Limited

Completed ##-Mar-2017 Novaliq GmbH Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations.

  • Analgesic
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Australasia

All trial arms used the same nasal spray delivery system.

  • Allergy Drug
  • Allergy Immunotherapy
  • Therapy
  • Australasia
  • Product Initiative

The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatment of cancer and inflammatory diseases.

  • Hospital
  • Pharmaceutical
  • Therapy
  • Australasia
  • Product Initiative

The company uses various technologies for the development of drugs including matrix-based extended release, rapid-action orally-disintegrating technology, and self emulsifying drug delivery system.

  • Genitourinary System Disease
  • Therapy
  • Australasia
  • Company
  • Product Initiative
  • PARTNERSHIPS

It is formulated as an injectable, non-erodible, intravitreal implant in a ##-month sustained-release drug delivery system.

  • Pharmaceutical
  • Therapy
  • Australasia
  • Australia
  • Supply

Dr Carleen Cullinane, Co-Head of Peter Mac' s Translational Research Lab said, " We are enthusiastic to work with Starpharma to develop DEP®dendrimer drug delivery combinations.

  • Health Services
  • Specialty Hospital
  • Therapy
  • Australasia
  • Deals & Alliance

The company uses various technologies for the development of drugs including matrix-based extended release, rapid-action orally-disintegrating technology, and self emulsifying drug delivery system.

  • Autoimmune Disease
  • Therapy
  • Type 2 Diabetes
  • Australasia
  • Product Initiative

DEAL IN BRIEF PARTNERSHIP Update on September ##, 2009: Sagent announced the launch of Adenosine injection, USP, an anti arrhythmic drug used to treat paroxysmal supraventricular tachycardia.

  • Pharmaceutical
  • Therapy
  • Australasia
  • M&A
  • Strides Shasun Ltd